Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance
Go back to Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance| Gilead Sciences (NASDAQ: GILD) | Delayed: 146.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.34 | 52 Week High | $108.63 | |||
| Open | $146.34 | 52 Week Low | $71.39 | |||
| Day High | $146.34 | P/E | 80.85 | |||
| Day Low | $146.34 | EPS | $1.81 | |||
| Volume | 3,109 | |||||

